Ben Dickinson – Page 5 – Biosimilars Adoption | Breaking through Barriers

Biosimilar Product Information

Biosimilar medicines uptake: The role of the clinical pharmacist

Efficacy and Safety of Adalimumab Biosimilars: Current Critical Clinical Data in Rheumatoid Arthritis

Awareness, Knowledge, and Perceptions of Biosimilars Among Specialty Physicians

The Complexities of Biosimilars and the Regulatory Approval Process

Adalimumab Biosimilars in the Treatment of Rheumatoid Arthritis: A Systematic Review of the Evidence for Biosimilarity

Purple Book: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations

Overview of Biosimilars for Immune-Mediated Inflammatory Diseases: Summary of Current Evidence

Best Practices in Multiple Sclerosis Therapies

Biosimilars – Providing Affordable, Accessible Care for Patients